Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

CT colleges earn places in national rankings

The University of Connecticut earned a slot in the top ten 4-year public higher education institutions in the nation with the best graduation rates, ranking 5th in...

| By Kelley Gipson

CT colleges focus on new business partnerships

Many Connecticut colleges in 2023 will continue to focus on bouncing back from declining enrollment and financial challenges brought on by the pandemic, which forced...

| By Kelley Gipson

UConn TCS publishes 2022 annual report

UConn TCS (Technology Commercialization Services) has published its annual report for 2022. “TCS’s success can be illustrated through our stories of inventorship but also through the...

| By Kelley Gipson

BioXcel reports promising results re cancer trial

BioXcel Therapeutics has announced promising top-line data from its Phase 2 trial of BXCL701, the company’s investigational, oral innate immune activator, in combination with KEYTRUDA® (pembrolizumab) in...

| By Kelley Gipson

View this email in your browser January 12, 2023 BioCT member Enko discovers and develops novel products for farmers to protect their crops from pests and disease....

| By Kelley Gipson

UConn president’s goals include climate change

Newly-minted UConn President Radenka Maric has ambitious goals and plans — related to climate change, business partnerships, research and fundraising — as she leads the...

| By Kelley Gipson

Neuroimaging holds promise in mental health

Neuroimaging technology has been shown to hold great promise in helping clinicians link specific symptoms of mental health disorders to abnormal patterns of brain activity....

| By Kelley Gipson

UConn, JAX analyze brain cancer signatures

UConn Health and The Jackson Laboratory for Genomic Medicine have been collaborating on brain tumor genomic sequencing for the last five years. Most recently, they’re employing a methylome profiling...

| By Kelley Gipson

Jumo Health aims to increase clinical trial diversity

The FDA has issued draft guidance to help pharmaceutical companies enroll more participants from underrepresented populations into clinical trials. That’s a challenge that New Haven-based Jumo...